Robert A Vierkant Selected Research

Rubella (German Measles)

11/2011	Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
10/2010	Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment.
8/2010	A qualitative and quantitative comparison of two rubella virus-specific IgG antibody immunoassays.
7/2010	Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity.
4/2010	SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.
4/2010	Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.
2/2010	Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses.
2/2010	Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes.
12/2009	Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity.
11/2009	Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Vierkant Research Topics

Disease

50	Neoplasms (Cancer) 04/2022 - 02/2002
35	Measles 08/2012 - 03/2002
34	Breast Neoplasms (Breast Cancer) 07/2021 - 01/2002
32	Ovarian Neoplasms (Ovarian Cancer) 10/2016 - 12/2004
25	Rubella (German Measles) 11/2011 - 05/2003
20	Ovarian Epithelial Carcinoma 01/2018 - 12/2004
16	Mumps 11/2011 - 03/2002
12	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 12/2006
8	Carcinogenesis 04/2015 - 06/2009
7	Carcinoma (Carcinomatosis) 04/2022 - 07/2010
7	Hyperplasia 12/2017 - 03/2008
6	Smallpox (Variola) 01/2016 - 02/2009
5	Inflammation (Inflammations) 01/2022 - 12/2008
5	Vaccinia 09/2012 - 02/2009
4	Endometriosis 01/2022 - 01/2011
3	Breast Diseases (Breast Disease) 01/2016 - 06/2006
2	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016 - 02/2014
2	Obesity 01/2016 - 04/2014
2	Endometrioid Carcinoma 04/2014 - 08/2013
2	Microsatellite Instability 09/2012 - 01/2012
2	Infections 02/2010 - 02/2010
2	Aneuploidy (Aneuploid) 01/2010 - 07/2007
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022

Drug/Important Bio-Agent (IBA)

23	VaccinesIBA 01/2016 - 05/2003
22	CytokinesIBA 11/2012 - 02/2005
16	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2008
15	Hormones (Hormone)IBA 01/2022 - 02/2002
14	HLA Antigens (Human Leukocyte Antigens)IBA 10/2011 - 06/2002
13	AntibodiesIBA 01/2017 - 06/2002
10	Immunoglobulin G (IgG)IBA 10/2011 - 05/2002
9	Interleukin-6 (Interleukin 6)IBA 04/2014 - 05/2009
9	Interleukin-2 (IL2)IBA 01/2012 - 11/2006
8	Estrogen ReceptorsIBA 01/2021 - 02/2002
8	Folic Acid (Vitamin M)FDA LinkGeneric 04/2015 - 01/2002
8	Interleukin-10 (Interleukin 10)IBA 04/2014 - 11/2006
7	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2003
7	ParaffinIBA 01/2021 - 07/2010
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2008
7	Estrogens (Estrogen)FDA Link 01/2016 - 02/2002
7	EnzymesIBA 05/2012 - 05/2002
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 06/2007
6	Progesterone FDA LinkGeneric 01/2016 - 02/2002
5	Biological ProductsIBA 03/2015 - 06/2006
5	Transcription Factors (Transcription Factor)IBA 01/2015 - 06/2009
5	Cytokine Receptors (Cytokine Receptor)IBA 11/2012 - 01/2007
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 05/2009
5	Progesterone Receptors (Progesterone Receptor)IBA 02/2011 - 02/2002
5	Peptides (Polypeptides)IBA 04/2007 - 06/2002
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
4	MicroRNAs (MicroRNA)IBA 01/2016 - 06/2011
4	CarbonIBA 10/2014 - 04/2008
4	Neutralizing AntibodiesIBA 06/2012 - 05/2009
4	InterferonsIBA 05/2012 - 01/2007
4	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 11/2011 - 02/2005
4	HLA-DQB1 antigen (HLA DQB1)IBA 10/2011 - 05/2008
4	Measles VaccineIBA 12/2005 - 05/2003
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2020 - 06/2007
3	RNA (Ribonucleic Acid)IBA 11/2017 - 01/2013
3	Antiviral Agents (Antivirals)IBA 01/2016 - 02/2010
3	Oral ContraceptivesIBA 01/2016 - 04/2014
3	Interleukin-18 (Interleukin 18)IBA 05/2013 - 12/2008
3	EpitopesIBA 03/2012 - 03/2004
3	InterleukinsIBA 01/2012 - 01/2007
3	Viral VaccinesIBA 01/2011 - 04/2007
3	AntigensIBA 11/2006 - 05/2004
2	PlatinumIBA 04/2022 - 08/2011
2	Genetic Markers (Genetic Marker)IBA 03/2016 - 04/2007
2	Carboplatin (JM8)FDA LinkGeneric 12/2015 - 08/2011
2	Histones (Histone)IBA 12/2015 - 01/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2015 - 08/2011
2	Dihydrotachysterol (AT 10)IBA 08/2015 - 06/2010
2	Indicators and Reagents (Reagents)IBA 02/2014 - 10/2006
2	Cytochrome P-450 CYP2C8IBA 05/2013 - 01/2011
2	ImmunosorbentsIBA 05/2012 - 01/2012
2	Phosphotransferases (Kinase)IBA 03/2012 - 01/2010
2	HLA-B Antigens (HLA-B)IBA 06/2011 - 02/2007
2	Aromatase (CYP19)IBA 02/2011 - 04/2007
2	LumicanIBA 01/2011 - 01/2008
2	DecorinIBA 01/2011 - 01/2008
2	Interleukin-12 Subunit p40IBA 04/2010 - 11/2006
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2010 - 02/2010
2	Rubella VaccineIBA 11/2009 - 02/2007
2	beta CateninIBA 09/2009 - 08/2008
2	alpha-Tocopherol FDA Link 07/2008 - 12/2006
2	beta Carotene (Betacarotene)FDA Link 07/2008 - 12/2006
2	HLA-DRB1 Chains (HLA DRB1)IBA 02/2007 - 03/2004
2	Interferon-gamma (Interferon, gamma)IBA 02/2007 - 12/2005
2	HLA-DRB1*03:01 antigenIBA 06/2006 - 03/2004
2	Viral AntigensIBA 03/2006 - 05/2005
2	Interleukin-4 (Interleukin 4)IBA 12/2005 - 02/2005
1	taxaneIBA 04/2022
1	SmokeIBA 01/2022
1	Talc FDA Link 01/2022

Therapy/Procedure

9	Therapeutics 01/2022 - 04/2012
4	Drug Therapy (Chemotherapy) 04/2022 - 01/2002
2	Mammaplasty (Breast Reconstruction) 11/2020 - 05/2012
2	Chemoprevention 01/2016 - 03/2008
2	Tubal Sterilization (Tubal Ligation) 01/2016 - 05/2013
1	Neoadjuvant Therapy 04/2022